Press release
Nuclear Medicine/Radiopharmaceuticals Market is anticipated to grow at a Robust CAGR of 20.1% during the forecast period 2023-2032
The global nuclear medicine/radiopharmaceuticals market was valued at USD 7.8 billion in 2022 and it is anticipated to grow up to USD 48.8 billion by 2032, at a CAGR of 20.1% during the forecast period.To Remain 'Ahead' Of Your Competitors, Request for A Sample: https://www.globalinsightservices.com/request-sample/GIS10340
Nuclear medicine is primarily a specialized area of radiology that employs very small amounts of radioactive materials, called radiopharmaceuticals for examining organ functions and structures. Radiopharmaceuticals are pharmaceutical formulations comprising radioactive isotopes that are used in diagnosis and therapeutics. They are simple and small substances that contain a radioactive substance that is used in the treatment of cancer and cardiac & neurological disorders.
Market Trends and Drivers:
Increasing incidence and prevalence of target conditions will boost the business progression. The rising incidence and prevalence of cancer and cardiovascular disease (CVD) is a key factor supporting market growth. Most cases can be prevented through early detection and treatment; nuclear medicine plays a significant role in these areas. According to the WHO, cancer was the leading cause of death in 2020, accounting for nearly 10 million deaths.
Read more about Nuclear Medicine/Radiopharmaceuticals Market here: https://www.globalinsightservices.com/reports/nuclear-medicine-radiopharmaceuticals-market/
Annually, 19.3 million new cancer cases are expected to be reported worldwide by 2025. According to the WHO, globally, 17.9 million individuals died from CVD in 2019, accounting for 32% of the overall deaths globally. This figure is expected to reach 23.3 million by 2030. As nuclear medicine plays a significant role in disease diagnosis and treatment, the rising prevalence of these diseases is expected to drive the growth of the nuclear medicine market during the forecast period.
COVID-19 Impact:
Coronavirus disease 2019 (COVID‐19) is an acute respiratory infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Largely unknown before the outbreak began in Wuhan, China, in December 2019, COVID-19 has moved from a regional crisis to a global pandemic in just a few weeks. The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11, 2020.
Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS10340
Global Nuclear Medicine/Radiopharmaceuticals Market Segmentation:
By Type:
• Diagnostics
o SPECT
o PET
• Therapeutics
o Alpha Emitters
o Beta Emitters
o Brachytherapy
By Application:
• Oncology
• Cardiology
• Neurology
• Orthopedics
• Thyroid
Major Players in the Global Nuclear Medicine/Radiopharmaceuticals Market:
The key players in the market are Cardinal Health (US), GE Healthcare (US), Curium (France), Lantheus Medical Imaging (US), Bayer AG (Germany), Bracco Imaging (Italy), Eczacýbaþý-Monrol Nuclear Products (Turkey), Nordion (Canada), Advanced Accelerator Applications (France), NTP Radioisotopes (South Africa), among others.
For In-Depth Competitive Analysis, Purchase this Report: https://www.globalinsightservices.com/checkout/single_user/GIS10340
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nuclear Medicine/Radiopharmaceuticals Market is anticipated to grow at a Robust CAGR of 20.1% during the forecast period 2023-2032 here
News-ID: 3003342 • Views: …
More Releases from Global Insight Services

Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved…

GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the…

Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview
Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger…

Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview
Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire…
More Releases for Nuclear
Nuclear Energy Market is Going to Boom : GE Hitachi Nuclear Energy, China Nation …
HTF MI introduces new research on Nuclear Energy covering the micro level of analysis by competitors and key business segments (2023-2029). The Nuclear Energy explores a comprehensive study of various segments like opportunities, size, development, innovation, sales, and overall growth of major players. The research is carried out on primary and secondary statistics sources and it consists of both qualitative and quantitative detailing.
Some of the major key players profiled…
Nuclear Technology Market Is Booming Worldwide | Areva, Foro Nuclear, Emirates N …
Advance Market Analytics published a new research publication on "Nuclear Technology Market Insights, to 2027" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Nuclear Technology market was mainly driven by the increasing R&D spending across the world.
Get Free Exclusive PDF Sample Copy of…
Nuclear Reactor Market - Crucial business trends 2025 | FirstEnergy Nuclear Gene …
Global Nuclear Reactor Market: Snapshot
The global market for nuclear reactors is likely to take significant strides, thanks to the growing need for emission-free energy generation systems over the globe. The emergence of new nuclear power plants has also been responsible for the progress of the worldwide nuclear reactor market. In June 2017, for example, Russia announced that it was in advanced stages of constructing the world’s first ever ‘floating’…
Nuclear Reactor Market - Promising growth opportunities 2025 | FirstEnergy Nucle …
Global Nuclear Reactor Market: Snapshot
The global market for nuclear reactors is likely to take significant strides, thanks to the growing need for emission-free energy generation systems over the globe. The emergence of new nuclear power plants has also been responsible for the progress of the worldwide nuclear reactor market. In June 2017, for example, Russia announced that it was in advanced stages of constructing the world’s first ever ‘floating’…
Nuclear Energy Industry Analysis of Nuclear Fuels Market 2017-2021
Nuclear fuel is a substance used to initiate and sustain a nuclear fission reaction in nuclear power stations to generate heat. This heat powers turbine to produce usable electrical energy. A nuclear reactor is a structure in which fissile material undergoes a controlled, self-sustaining nuclear reaction with simultaneous release of energy, which can be used to generate electricity.
. .
– Get Sample Report_https://www.researchmoz.us/enquiry.php?type=S&repid=1069449
' '
Global nuclear fuels market to grow…
UAE Nuclear Power Sector UAE Nuclear Power Sales Report
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. UAE Power Sector Scenario
1.1 Existing Power Generation Outlook
1.2 Current & Projected Power Demand
2. Why UAE Energy Policy beyond Oil & Gas?
3. UAE Nuclear Power Sector Overview
3.1 UAE Entering into Nuclear Power Sector
3.2 Nuclear Policy Overview
4. UAE Nuclear Power Sector Dynamics
4.1 Favorable Parameters
4.2 Nuclear Power Sector…